Loss of lipid phosphatase SHIP1 promotes macrophage differentiation through suppression of dendritic cell differentiation
Open accessAbstract
SH2-containing inositol 5ʹ-phosphatase-1 (SHIP1) deficiency in mice results in abnormal myeloid expansion, and proinflammatory conditions in the lung. However, the mechanisms involved in SHIP1-mediated regulation of myeloid differentiation remain unclear. Here we show that SHIP1 is a key regulator of early differentiation for dendritic cells (DCs). We also provide critical evidence to modify the function of SHIP1 in in vitro development of BMDCs using the recent framework of defining DCs. We found that loss of SHIP1 suppresses GM-CSF-induced formation of bone marrow-derived DC (BMDC) colonies, leading to reduced BMDC number in BM cell culture. The number of maturated BMDCs decreased in SHIP1-KO culture, due to reduction of immature BMDCs, suggesting SHIP1 is critical for lineage commitment rather than for maturation from myeloid precursors to DCs. We further showed that F4/80+/MHCIIlow BM macrophage-like cells (BMMs) were the main population of SHIP1-KO BM culture. Treatment of wild-type BM culture with 3 α-aminocholestane (3AC), a specific inhibitor for functional activity of SHIP1, caused a similar developmental defect in BMDCs as seen in SHIP1-KO cells, resulting in the absence of BMDC colony, and increased number of BMMs in BM culture. In conclusion, our results suggest that differentiation of BMDCs are markedly impaired under SHIP1 deficient condition, which causes skewed development of myeloid lineage cells manifested as pathological conditions associated with an excess of macrophage population.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
3-alpha-Aminocholestane (3AC) is a selective inhibitor of INPP5D.
“Here, we used 3-alpha-Aminocholestane (3AC), a compound previously reported to be a selective inhibitor of INPP5D39, which has been utilized in several studies to reduce INPP5D activity in vivo in mice and in vitro cell culture39–47.”
From INPP5D regulates inflammasome activation in human microglia (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341 · see citing works
Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M.-Y., Paraiso, K. H. T., Engelman, R. W., & Kerr, W. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902844 · Cited by 140 · see citing works
Flagged first, then by citations
Research works printed but not linked: 31
- Hashimoto D, Miller J, Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity. 2011;35:323-335. doi:10.1016/j. immuni.2011.09.007. · DOI
- Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693-1702.
- Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu XL, Trinchieri G, O'Garra A, Liu Y-J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med. 2002;195:953-958.
- Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phos- phatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci U S A. 1996;93:1689-1693.
- Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4- bisphosphate. Science. 1997;275:665-668.
- Ivetac I, Gurung R, Hakim S, Horan KA, Sheffield DA, Binge LC, Majerus PW, Tiganis T, Mitchell CA. Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1. EMBO Rep. 2009;10:487-493. doi:10.1038/ embor.2009.28. · DOI
- Fuhler GM, Brooks R, Toms B, Iyer S, Gengo EA, Park MY, Gumbleton M, Viernes DR, Chisholm JD, Kerr WG. Therapeutic potential of SH2 domain-containing inositol-5ʹ-phos- phatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol Med. 2012;18:65-75. doi:10.2119/molmed.2011.00178. · DOI · Paper page
- Gumbleton M, Sudan R, Fernandes S, Engelman RW, Russo CM, Chisholm JD, Chappel SM, Kerr WG. Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves anti- tumor immunity and survival. Sci Signal. 2017:10 (500). pii: eaam5353. doi:10.1126/scisignal.aam5753. · DOI
- Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998;12:1610-1620.
- Collazo MM, Paraiso KH, Park MY, Hazen AL, Kerr WG. Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP. Eur J Immunol. 2012;42:1785-1795. doi:10.1002/ eji.201142092. · DOI
- Hadidi S, Antignano F, Hughes MR, Wang SK, Snyder K, Sammis GM, Kerr WG, McNagny KM, Zaph C. Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection. Mucosal Immunol. 2012;5:535-543. doi:10.1038/mi.2012.29. · DOI
- Maxwell MJ, Srivastava N, Park MY, Tsantikos E, Engelman RW, Kerr WG, Hibbs ML. SHIP-1 deficiency in the myeloid compart- ment is insufficient to induce myeloid expansion or chronic inflam- mation. Genes Immun. 2014;15:233-240. doi:10.1038/gene.2014.9. · DOI
- Gold MJ, Antignano F, Hughes MR, Zaph C, McNagny KM. Dendritic-cell expression of Ship1 regulates Th2 immunity to helminth infection in mice. Eur J Immunol. 2016;46:122-130. doi:10.1002/eji.201545628. · DOI
- Neill L, Tien AH, Rey-Ladino J, Helgason CD. SHIP-deficient mice provide insights into the regulation of dendritic cell devel- opment and function. Exp Hematol. 2007;35:627-639. doi:10.1016/j.exphem.2007.01.048. · DOI
- Antignano F, Ibaraki M, Kim C, Ruschmann J, Zhang A, Helgason CD, Krystal G. SHIP is required for dendritic cell maturation. J Immunol. 2010;184:2805-2813. doi:10.4049/ jimmunol.0903170. · DOI
- Tamoutounour S, Henri S, Lelouard H, de Bovis B, de Haar C, van der Woude CJ, Woltman AM, Reyal Y, Bonnet D, Sichien D, et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol. 2012;42:3150-3166. doi:10.1002/eji.201242847. · DOI
- Na YR, Jung D, Gu GJ, Seok SH. GM-CSF grown bone marrow derived cells are composed of phenotypically different dendritic cells and macrophages. Mol Cells. 2016;39:734-741. doi:10.14348/ molcells.2016.0160. · DOI
- So EY, Ouchi T. Translational initiation regulated by ATM in dendritic cells development. Cell Death Dis. 2014;5:e1418. doi:10.1038/cddis.2014.362. · DOI
- Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S. Generation of tumor immunity by bone marrow- derived dendritic cells correlates with dendritic cell maturation stage. J Immunol. 1999;162:168-175.
- Lapointe R, Toso JF, Butts C, Young HA, Hwu P. Human den- dritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J Immunol. 2000;30:3291-3298. doi:10.1002/1521-4141(200011) 30:11<3291::AID-IMMU3291>3.0.CO;2-2. · DOI
- Lin HH, Faunce DE, Stacey M, Terajewicz A, Nakamura T, Zhang-Hoover J, Kerley M, Mucenski ML, Gordon S, Stein- Streilein J. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in periph- eral tolerance. J Exp Med. 2005;201:1615-1625. doi:10.1084/ jem.20042307. · DOI
- Pavli P, Hume DA, Van De Pol E, Doe WF. Dendritic cells, the major antigen-presenting cells of the human colonic lamina pro- pria. Immunology. 1993;78:132-141.
- Stenger EO, Turnquist HR, Mapara MY, Thomson AW. Dendritic cells and regulation of graft-versus-host disease and graft-versus- leukemia activity. Blood. 2012;119:5088-5103. doi:10.1182/blood- 2011-11-364091. · DOI
- Duffner UA, Maeda Y, Cooke KR, Reddy P, Ordemann R, Liu C, Ferrara JLM, Teshima T. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol. 2004;172:7393-7398.
- Ghansah T, Paraiso KH, Highfill S, Desponts C, May S, McIntosh JK, Wang J-W, Ninos J, Brayer J, Cheng F, et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allo- geneic T cell responses. J Immunol. 2004;173:7324-7330.
- Zhou P, Kitaura H, Teitelbaum SL, Krystal G, Ross FP, Takeshita S. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27. J Immunol. 2006;177:8777-8784.
- Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, Goubau D, Reis E Sousa C. GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+) MHCII(+) macrophages and dendritic cells. Immunity. 2015;42:1197-1211. doi:10.1016/j.immuni.2015.05.018. · DOI
- Paraiso KH, Ghansah T, Costello A, Engelman RW, Kerr WG. Induced SHIP deficiency expands myeloid regulatory cells and abro- gates graft-versus-host disease. J Immunol. 2007;178:2893-2900.
- Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity. 2004;21:227-239. doi:10.1016/j.immuni.2004.07.010. · DOI
- Becker L, Liu NC, Averill MM, Yuan W, Pamir N, Peng Y, Irwin AD, Fu X, Bornfeldt KE, Heinecke JW, et al. Unique proteomic signatures distinguish macrophages and dendritic cells. PLoS One. 2012;7:e33297. doi:10.1371/journal.pone.0033297. · DOI
- Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone mar- row. J Immunol Methods. 1999;223:77-92.
Cited by
Sorted by citations
INPP5D regulates inflammasome activation in human microglia
Chou, V., Pearse, R. V., Aylward, A. J., Ashour, N., Taga, M., Terzioglu, G., Fujita, M., Fancher, S. B., Sigalov, A., Benoit, C. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42819-w · Cited by 79 · see citing works
Loss of <i>Inpp5d</i> has disease‐relevant and sex‐specific effects on glial transcriptomes
Dabin, L. C., Kersey, H., Kim, B., Acri, D. J., Sharify, D., Lee‐Gosselin, A., Lasagna‐Reeves, C. A., Oblak, A. L., Lamb, B. T., & Kim, J. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13901 · Cited by 10 · see citing works
INPP5D/SHIP1 regulates inflammasome activation in human microglia
Chou, V., Fancher, S. B., Pearse, R. V., Lee, H., Lam, M., Seyfried, N. T., Bennett, D. A., De Jager, P. L., Menon, V., & Young-Pearse, T. L. (2023) · doi:10.1101/2023.02.25.530025 · Cited by 8 · see citing works
- Authors
- So, E. Y., Sun, C., Reginato, A. M., Dubielecka, P. M., Ouchi, T., & Liang, O. D.
- Affiliations
- Brown University (US)
- Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, USA
- Roswell Park Comprehensive Cancer Center (US)
- Corresponding author
- So, Eui Young
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2018-10-02
- Volume
- 20
- Issue
- 2
- Pages
- 201-211
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- PMC
- PMC6343724
- OpenAlex
- W2895689046
- Cited by
- 10
- References
- 2
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1
- FWCI
- 0.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Biology & Therapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (R01 HL123965, R01 HL112860, R01 DK112808, P20 GM103652, P20 GM104937, T32 HL116249, P20 GM119943)
- Rhode Island Foundation, Medical Research Fund Nr. (20144121)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SHIP1, inositol polyphosphate 5-phosphatase, dendritic cell differentiation, macrophage differentiation, myeloid lineage commitment, bone marrow-derived dendritic cells, GM-CSF, macrophage-like cells, myeloid expansion, lung inflammation
- MeSH terms
- Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Animals, Cell Differentiation, Dendritic Cells, Humans, Lipids, Macrophages, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review